Cited by 238Genetic Neurodegenerative DiseasesNeurological diseases and metabolismAdvanced MRI Techniques and Applications

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

Bartzokis, George, Lu, Po H., Tishler, Todd A., Fong, Sophia M., Oluwadara, Bolanle, Finn, J. Paul, Huang, Danny, Bordelon, Yvette, Mintz, Jim, Perlman, Susan·2007·Neurochemical Research

DOI 10.1007/s11064-007-9352-7

Open this paper in CoChat — free account

Abstract

Background Postmortem and in vivo imaging data support the hypothesis that premature myelin breakdown and subsequent homeostatic remyelination attempts with increased oligodendrocyte and iron levels may contribute to Huntington's Disease (HD) pathogenesis and the symmetrical progress of neuronal loss from earlier-myelinating striatum to later-myelinating regions. A unique combination of in vivo tissue integrity and iron level assessments was used to examine the hypothesis.Methods A method that uses two Magnetic resonance imaging (MRI) instruments operating at different field-strengths was used to quantify the iron content of ferritin molecules (ferritin iron) as well as tissue integrity in eight regions in 11 HD and a matched group of 27 healthy control subjects. Three white matter regions were selected based on their myelination pattern (early to later-myelinating) and fiber composition. These were frontal lobe white matter (Fwm) and splenium and genu of the corpus callosum (Swm and Gwm). In addition, gray matter structures were also chosen based on their myelination pattern and fiber composition. Three striatum structures were assessed [caudate, putamen, and globus pallidus (C, P, and G)] as well as two comparison gray matter regions that myelinate later in development and are relatively spared in HD [Hippocampus (Hipp) and Thalamus (Th)].Results Compared to healthy controls, HD ferritin iron levels were significantly increased in striatum C, P, and G, decreased in Fwm and Gwm, and were unchanged in Hipp, Th, and Swm. Loss of tissue integrity was observed in C, P, Fwm, and especially Swm but not Hipp, Th, G, or Gwm. This pattern of findings was largely preserved when a small subset of HD subjects early in the disease process was examined.Conclusions The data suggest early in the HD process, myelin breakdown and changes in ferritin iron distribution underlie the pattern of regional toxicity observed in HD. Prospective studies are needed to verify myelin breakdown and increased iron levels are causal factors in HD pathogenesis. Tracking the effects of novel interventions that reduce myelin breakdown and iron accumulation in preclinical stages of HD could hasten the development of preventive treatments.

Integrity signals

Registry

Crossref · 10.1007/s11064-007-9352-7

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tests for comparing elements of a correlation matrix
Steiger, J. H. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.2.245 · Cited by 4,621 · cited 1×
“were performed using Hotelling’s statistic [60], a test for the difference between two non-independent correlations [61].”
Method
Huntington's disease
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,691
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,107
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Huntington Disease
Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,305
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Self-citation

Show all 94 references

Research works printed but not linked: 5

Harper PS, Shaw D (1996) Huntington’s disease: genetic and molecular studies. In: Harper PS (eds) Huntington’s disease 2nd edn. W.B.Saunders, Philadelphia, pp 241–293
Jones AL (1996) The Huntington’s disease gene and its protein product. In: Harper PS (eds) Huntington’s disease, 2 edn. W.B.Saunders, Philadelphia, pp 293–316
Bruyn GW (1973) Neuropathological changes in Huntington’s chorea. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 399–403
Liss L, Paulson GW, Sommer A (1973) Rigid form of Huntington’s chorea: a clinicopathological study of three cases. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 405–424
Klintworth GK (1973) Huntington’s chorea—morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN (eds) Advances in neurology. Huntington’s chorea, vol 1. 1872–1972. Raven Press, New York, pp 353–368

Sorted by citations

The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oligodendrocytes and myelination: The role of iron
Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., & Connor, J. R. (2008) · Glia · doi:10.1002/glia.20784 · Cited by 615
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 594
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Self-citation
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., & Adalsteinsson, E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.077 · Cited by 499
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
The life, death, and replacement of oligodendrocytes in the adult CNS
McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 474
A delicate balance: Iron metabolism and diseases of the brain
Hare, D. J., Ayton, S., Bush, A. I., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 459
Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
Boudreau, R. L., McBride, J. L., Martins, I., Shen, S., Xing, Y., Carter, B. J., & Davidson, B. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.17 · Cited by 341
Integrated Laplacian‐based phase unwrapping and background phase removal for quantitative susceptibility mapping
Li, W., Avram, A., Wu, B. H., Xiao, X., & Liu, C. (2013) · NMR in Biomedicine · doi:10.1002/nbm.3056 · Cited by 311
Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer’s Disease Detected in vivo with Magnetic Resonance Imaging
Raven, E. P., Lu, P. H., Tishler, T. A., Heydari, P., & Bartzokis, G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130209 · Cited by 270
Self-citation
The transition metals copper and iron in neurodegenerative diseases
Rivera-Mancía, S., Pérez‐Neri, I., Ríos, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 247
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA)
Kruer, M. C., Paisán‐Ruiz, C., Boddaert, N., Yoon, M. Y., Hama, H., Gregory, A., Malandrini, A., Woltjer, R. L., Münnich, A., Gobin, S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22122 · Cited by 239
Striatal and white matter predictors of estimated diagnosis for Huntington disease
Paulsen, J. S., Nopoulos, P., Aylward, E., Ross, C. A., Johnson, H. J., Magnotta, V. A., Juhl, A., Pierson, R. K., Mills, J. A., Langbehn, D. R., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.003 · Cited by 223
PGC-1α, mitochondrial dysfunction, and Huntington's disease
Johri, A., Chandra, A., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.016 · Cited by 227
Diffusion tensor imaging of deep gray matter brain structures: Effects of age and iron concentration
Adolf Pfefferbaum, A., Elfar Adalsteinsson, A., Torsten Rohlfing, B., & Sullivan, E. V. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.013 · Cited by 190
Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes
Huang, B., Wei, W., Wang, G., Gaertig, M. A., Feng, Y., Wang, W., Li, X., & Li, S. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.026 · Cited by 179
Iron dysregulation in movement disorders
Dušek, P., Jankovic, J. J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 175
Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases
Hammond, K. E., Lupo, J., Xu, D., Metcalf, M., Kelley, D. A. C., Pelletier, D., Chang, S. M., Mukherjee, P., Vigneron, D. B., & Nelson, S. J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.037 · Cited by 166
MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase (SWI) methods
Pfefferbaum, A., Elfar Adalsteinsson, A., Torsten Rohlfing, B., & Sullivan, E. V. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.006 · Cited by 165
Development of biomarkers for Huntington's disease
Weir, D. W., Sturrock, A., & Leavitt, B. R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70070-9 · Cited by 162
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Ettle, B., Schlachetzki, J. C. M., & Winkler, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9205-3 · Cited by 160
Alterations in Brain Transition Metals in Huntington Disease
Rosas, H. D., Chen, Y. I., Doros, G. D., Salat, D. H., Chen, N., Kwong, K. K., Bush, A. I., Fox, J. H., & Hersch, S. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2945 · Cited by 160
Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 154
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 157
Cerebral cortex structure in prodromal Huntington disease
Nopoulos, P., Aylward, E., Ross, C. A., Johnson, H. J., Magnotta, V. A., Juhl, A. R., Pierson, R. K., Mills, J. A., Langbehn, D. R., & Paulsen, J. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.014 · Cited by 154
Role and mechanism of ferroptosis in neurological diseases
Ou, M., Jiang, Y., Ji, Y., Zhou, Q., Du, Z., Zhu, H., & Zhou, Z. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101502 · Cited by 150
Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease
Bergen, J. M. G. V., Hua, J., Unschuld, P. G., Lim, I. A. L., Jones, C. K., Margolis, R. L., Ross, C. A., van Zijl, P. C. M., & Li, X. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4617 · Cited by 140
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
Popescu, B. F. G., Frischer, J. M., Webb, S. M., Tham, M., Adiele, R. C., Robinson, C. A., Fitz‐Gibbon, P. D., Weigand, S. D., Metz, I., Nehzati, S., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1696-8 · Cited by 138
Oligodendrocytes and Alzheimer's disease
Cai, Z., & Xiao, M. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1025778 · Cited by 140
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's Disease
Xiang, Z., Valenza, M., Cui, L., Leoni, V., Jeong, H.-K., Brilli, E., Zhang, J., Peng, Q., Duan, W., Reeves, S. A., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1291-11.2011 · Cited by 136
Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer’s Disease
Du, L., Zhao, Z., Cui, A., Zhu, Y., Zhang, L., Liu, J., Shi, S., Fu, C., Han, X., Gao, W., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00194 · Cited by 129
Longitudinal diffusion tensor imaging in Huntington's Disease
Weaver, K. E., Richards, T. L., Liang, O., Laurino, M., Samii, A., & Aylward, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.026 · Cited by 123
Iron dysregulation in Huntington's disease
Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 123
Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
Bardile, C. F., Garcia‐Miralles, M., Caron, N. S., Rayan, N. A., Langley, S. R., Harmston, N., Rondelli, A. M., Teo, R. T. Y., Waltl, S., Anderson, L. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818042116 · Cited by 119
Role of iron in neurodegenerative diseases
Li, K., & Reichmann, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1508-7 · Cited by 121
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
Leoni, V., & Caccia, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.025 · Cited by 124
The Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 115
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 118
Contrasting gray and white matter changes in preclinical Huntington disease
Stoffers, D., Sheldon, S. S., Kuperman, J. M., Goldstein, J. L., Corey‐Bloom, J., & Aron, A. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d8c20a · Cited by 106
Gender and Iron Genes May Modify Associations Between Brain Iron and Memory in Healthy Aging
Bartzokis, G., Lu, P. H., Tingus, K., Peters, D. G., Amar, C. P., Tishler, T. A., Finn, J. P., Villablanca, P. J., Altshuler, L. L., Mintz, J., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.22 · Cited by 104
Self-citation
Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study
D, J. F. D., Ng, A., Poudel, G. R., Stout, J. C., Churchyard, A., Chua, P. M.-L., Egan, G. F., & Georgiou‐Karistianis, N. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-310183 · Cited by 99
Diffusion Tensor Imaging in Huntington’s disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits
Bohanna, I., Georgiou‐Karistianis, N., Sritharan, A., Asadi, H., Johnston, L. A., Churchyard, A., & Egan, G. F. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9121-8 · Cited by 97
Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease
Jin, J., Peng, Q., Hou, Z., Jiang, M., Wang, X., Langseth, A. J., Tao, M., Barker, P. B., Mori, S., Bergles, D. E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv016 · Cited by 96
Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue
Kreilaus, F., Spiro, A. S., McLean, C. A., Garner, B., & Jenner, A. M. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12286 · Cited by 92
Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice
Park, H., Cho, B., Kim, H., Saito, T., Saido, T. C., Won, K.-J., & Kim, J. (2023) · Nature Communications · doi:10.1038/s41467-023-36519-8 · Cited by 92
CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease
Bendlin, B. B., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., Willette, A. A., Okonkwo, O. C., Sodhi, A., Ries, M. L., Birdsill, A. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037720 · Cited by 91
Multi-Modal Neuroimaging in Premanifest and Early Huntington’s Disease: 18 Month Longitudinal Data from the IMAGE-HD Study
D, J. F. D., Egan, G. F., Gray, M. A., Poudel, G. R., Churchyard, A., Chua, P. M.-L., Stout, J. C., & Georgiou‐Karistianis, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074131 · Cited by 90
Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease
Teo, R. T. Y., Hong, X., Yu-Taeger, L., Huang, Y., Tan, L. J., Xie, Y., To, X. V., Guo, L. T., Rajendran, R., Novati, A., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw122 · Cited by 92
Aging in deep gray matter and white matter revealed by diffusional kurtosis imaging
Gong, N.-J., Wong, C.-S., Chan, C.-C., Leung, L.-M., & Chu, Y.-C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.011 · Cited by 82
A Critical Review of White Matter Changes in Huntington’s Disease
Casella, C., Lipp, I., Rosser, A., Jones, D. K., & Metzler‐Baddeley, C. (2020) · Movement Disorders · doi:10.1002/mds.28109 · Cited by 82
Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease
Arteaga-Bracho, E. E., Gulinello, M. E., Winchester, M. L., Pichamoorthy, N., Petronglo, J. R., Zambrano, A. D., Inocencio, J. F., Jesus, C. D. D., Louie, J. O., Gökhan, Ş., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.006 · Cited by 86
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
Toonen, L. J. A., Overzier, M., Evers, M. M., León, L. G., van der Zeeuw, S. A. J., Mei, H., Kiełbasa, S. M., Goeman, J. J., Hettne, K. M., Magnússon, Ó. Þ., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0261-9 · Cited by 80
The emerging role of iron dyshomeostasis in the mitochondrial decay of aging
Xu, J., Marzetti, E., Seo, A. Y., Kim, J., Prolla, T. A., & Leeuwenburgh, C. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.04.007 · Cited by 77
Major Superficial White Matter Abnormalities in Huntington's Disease
Phillips, O. R., Joshi, S. H., Squitieri, F., Sánchez‐Castañeda, C., Narr, K. L., Shattuck, D. W., Caltagirone, C., Sabatini, U., & Paola, M. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00197 · Cited by 76
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
Alpaugh, M., Galleguillos, D., Forero, J. P., Morales, L. C., Lackey, S. W. K., Kar, P., Pardo, A. D., Holt, A., Kerr, B. J., Todd, K. G., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707763 · Cited by 74
Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
Paul, B. D., & Snyder, S. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00068 · Cited by 76
Myelin Breakdown in Human Huntington’s Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer
Bourbon‐Teles, J., Bells, S., Jones, D. K., Coulthard, E. J., Rosser, A., & Metzler‐Baddeley, C. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.042 · Cited by 74
Seeking huntington disease biomarkers by multimodal, cross‐sectional basal ganglia imaging
Sánchez‐Castañeda, C., Cherubini, A., Elifani, F., Péran, P., Orobello, S., Capelli, G., Sabatini, U., & Squitieri, F. (2012) · Human Brain Mapping · doi:10.1002/hbm.22019 · Cited by 73
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping
Yarnykh, V. L. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25811 · Cited by 70
Oligodendroglia and neurotrophic factors in neurodegeneration
Bankston, A. N., Mandler, M. D., & Feng, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1321-3 · Cited by 76
Multimodal MRI Analysis of the Corpus Callosum Reveals White Matter Differences in Presymptomatic and Early Huntington's Disease
Paola, M. D., Eileen Luders, A., Cherubini, A., Sánchez‐Castañeda, C., Thompson, P. M., Toga, A. W., Caltagirone, C., Orobello, S., Elifani, F., Squitieri, F., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr360 · Cited by 69
Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis
Ismail, N., Kureishy, N., Church, S. J., Scholefield, M., Unwin, R. D., Xu, J., Patassini, S., & Cooper, G. J. S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.052 · Cited by 67
Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment
Blockx, I., Groof, G. D., Verhoye, M., Audekerke, J. V., Raber, K. A., Poot, D. H. J., Sijbers, J., Osmand, A. P., von Hörsten, S., & der Linden, A. V. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.062 · Cited by 67
Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Bertrand, S., Hélesbeux, J., Larcher, G., & Duval, O. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/13895575113139990007 · Cited by 66
Altered brain iron content and deposition rate in Huntington’s disease as indicated by quantitative susceptibility MRI
Chen, L., Hua, J., Ross, C. A., Cai, S., van Zijl, P. C. M., & Li, X. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24358 · Cited by 62
Elevated brain iron is independent from atrophy in Huntington's Disease
Dumas, E. M., Versluis, M. J., van den Bogaard, S. J. A., van Osch, M. J. P., Hart, E. P., van Roon‐Mom, W., van Buchem, M. A., WEBB, A. G., van der Grond, J., & Roos, R. A. C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.056 · Cited by 62
Tractography of the Corpus Callosum in Huntington’s Disease
Phillips, O. R., Sánchez‐Castañeda, C., Elifani, F., Maglione, V., Pardo, A. D., Caltagirone, C., Squitieri, F., Sabatini, U., & Paola, M. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073280 · Cited by 58
Comparison of Histological Techniques to Visualize Iron in Paraffin-embedded Brain Tissue of Patients with Alzheimer’s Disease
van Duijn, S., Nabuurs, R. J. A., van Duinen, S. G., & Natté, R. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413501325 · Cited by 61
Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments
Bartzokis, G. (2011) · Frontiers in bioscience · doi:10.2741/3881 · Cited by 60
Self-citation
Gene therapy for Huntington's disease
Ramaswamy, S., & Kordower, J. H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.030 · Cited by 61
Focal dystonia and the Sensory-Motor Integrative Loop for Enacting (SMILE)
Perruchoud, D., Murray, M. M., Lefebvre, J., & Ionta, S. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00458 · Cited by 57
Iron and Alzheimer’s Disease: From Pathology to Imaging
Tran, D. Q., DiGiacomo, P., Born, D. E., Georgiadis, M., & Zeineh, M. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.838692 · Cited by 60
Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease
Rosas, H. D., Wilkens, P. J., Salat, D. H., Mercaldo, N. D., Vangel, M. G., Yendiki, A., & Hersch, S. M. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.01.029 · Cited by 54
Metal and complementary molecular bioimaging in Alzheimer's disease
Braidy, N., Poljak, A., Marjo, C. E., Rutlidge, H., Rich, A. M., Jayasena, T., Inestrosa, N. C., & Sachdev, P. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00138 · Cited by 53
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/2 Mouse Model of HD
Rattray, I., Smith, E. J., Gale, R., Matsumoto, K., Bates, G. P., & Modo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060012 · Cited by 52
Deep White Matter in Huntington's Disease
Phillips, O. R., Squitieri, F., Sánchez‐Castañeda, C., Elifani, F., Caltagirone, C., Sabatini, U., & Paola, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109676 · Cited by 52
Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases
Wang, Y., Li, H., He, Q., Zou, R., Cai, J., & Zhang, L. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01902-9 · Cited by 53
Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data
Domínguez, J. F., Stout, J. C., Poudel, G. R., Churchyard, A., Chua, P. M.-L., Egan, G. F., & Georgiou‐Karistianis, N. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156588 · Cited by 51
[Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].
Toxqui, L., Piero, A. D., Courtois, V., Bastida, S., Sánchez-Muniz, F. J., & Vaquero, M. P. (2010) · PubMed · doi:10.3305/nh.2010.25.3.4583 · Cited by 53
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
Cheng, Y., Peng, Q., Hou, Z., Aggarwal, M., Zhang, J., Mori, S., Ross, C. A., & Duan, W. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.022 · Cited by 50
Overdosing on iron: Elevated iron and degenerative brain disorders
D’Mello, S. R., & Kindy, M. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220953065 · Cited by 49
MRI measures of corpus callosum iron and myelin in early Huntington's disease
Paola, M. D., Phillips, O. R., Sánchez‐Castañeda, C., Pardo, A. D., Maglione, V., Caltagirone, C., Sabatini, U., & Squitieri, F. (2013) · Human Brain Mapping · doi:10.1002/hbm.22391 · Cited by 49
Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
Bono-Yagüe, J., Gómez-Escribano, A. P., Millán, J. M., & Vázquez‐Manrique, R. P. (2020) · Antioxidants · doi:10.3390/antiox9070577 · Cited by 52
Free radical biology in neurological manifestations: mechanisms to therapeutics interventions
Tripathi, R. S., Gupta, R. V., Sahu, M., Srivastava, D., Das, A., Ambasta, R. K., & Kumar, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16693-2 · Cited by 54
The role of iron in gray matter degeneration in Huntington's disease: A magnetic resonance imaging study
Sánchez‐Castañeda, C., Squitieri, F., Paola, M. D., Dayan, M., Petrollini, M., & Sabatini, U. (2014) · Human Brain Mapping · doi:10.1002/hbm.22612 · Cited by 46
Diffusion Tensor Imaging in Preclinical Huntington’s Disease
Magnotta, V. A., Kim, J., Koscik, T. R., Beglinger, L. J., Espinso, D., Langbehn, D. R., Nopoulos, P., & Paulsen, J. S. (2008) · Brain Imaging and Behavior · doi:10.1007/s11682-008-9051-2 · Cited by 46
Brain, blood, and iron: Perspectives on the roles of erythrocytes and iron in neurodegeneration
Prohaska, R., Sibon, O. C. M., Rudnicki, D. D., Danek, A., Hayflick, S. J., Verhaag, E. M., Vonk, J. J., Margolis, R. L., & Walker, R. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.006 · Cited by 46
Combining atlas-based parcellation of regional brain data acquired across scanners at 1.5T and 3.0T field strengths
Pfefferbaum, A., Torsten Rohlfing, B., Rosenbloom, M. J., & Sullivan, E. V. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.092 · Cited by 45
Phenolic Compounds of Therapeutic Interest in Neuroprotection
Nájera-Maldonado, J. M., Salazar, R., Fitz, P. Á., Quiroz, M. E. A., Flores‐Alfaro, E., Hernández‐Sotelo, D., Espinoza-Rojo, M., & Ramı́rez, M. (2024) · Journal of Xenobiotics · doi:10.3390/jox14010014 · Cited by 53
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
Scholefield, M., Church, S. J., Xu, J., Patassini, S., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641222 · Cited by 44
Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
Simmons, D. A. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170275 · Cited by 42
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
D’Egidio, F., Castelli, V., Cimini, A., & d’Angelo, M. (2023) · Antioxidants · doi:10.3390/antiox12030571 · Cited by 42
MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
Jurgens, C. K., Jasinschi, R., Ekin, A., Witjes‐Ané, M. W., van der Grond, J., Middelkoop, H. A. M., & Roos, R. A. C. (2010) · PLoS Currents · doi:10.1371/currents.rrn1173 · Cited by 42
The Corticospinal Tract in Huntington's Disease
Phillips, O. R., Squitieri, F., Sánchez‐Castañeda, C., Elifani, F., Griguoli, A. M., Maglione, V., Caltagirone, C., Sabatini, U., & Paola, M. D. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu065 · Cited by 41
Relationship between aging and T1 relaxation time in deep gray matter: A voxel‐based analysis
Okubo, G., Okada, T., Yamamoto, A., Fushimi, Y., Okada, T., Murata, K., & Togashi, K. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25590 · Cited by 42
Detection of axonal degeneration in a mouse model of Huntington’s disease: comparison between diffusion tensor imaging and anomalous diffusion metrics
Gatto, R. G., Ye, A. Q., Colon-Perez, L., Mareci, T. H., Lysakowski, A., Price, S. D., Brady, S. T., Karaman, M., Morfini, G., & Magin, R. L. (2019) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/s10334-019-00742-6 · Cited by 42
Myelin injury in the central nervous system and Alzheimer's disease.
Wang, S.-S., Zhang, Z., Zhu, T., Chu, S.-F., He, W.-B., & Chen, N.-H. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.003 · Cited by 40
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
Johnson, E. B., Parker, C. S., Scahill, R. I., Gregory, S., Papoutsi, M., Zeun, P., Osborne‐Crowley, K., Lowe, J., Nair, A., Estevez‐Fraga, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103266 · Cited by 39
Effects of aging and calorie restriction on white matter in rhesus macaques
Bendlin, B. B., Canu, E., Willette, A. A., Kastman, E. K., McLaren, D. G., Kosmatka, K. J., Xu, G., Field, A. S., Colman, R. J., Coe, C. L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.008 · Cited by 41

Authors: Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., & Perlman, S.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Bartzokis, George
ORCID: Lu, Po H.
Finn, J. Paul
Bordelon, Yvette
Mintz, Jim
Perlman, Susan
Venue: Neurochemical Research
Publisher: Springer Science and Business Media LLC
Published: 2007-05-05
Volume: 32
Issue: 10
Pages: 1655-1664
ISSN: 0364-3190 (ISSN-L)
1573-6903
DOI: 10.1007/s11064-007-9352-7
OpenAlex: W1986646115
Cited by: 238
References: 94
Citations by year: 2026: 7 · 2025: 13 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 14 · 2020: 11 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 9 · 2015: 24 · 2014: 16 · 2013: 18 · 2012: 18
FWCI: 2.92
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neurochemical Research (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
National Institutes of Health (5r03mh051928-02)
National Institute on Aging (R01AG027342, P50AG016570, AG 16570)
National Institute of Mental Health (MH6357-01A1, MH 51928, MH066029-01A2, R01MH066029)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords: Huntington's disease, myelin breakdown, tissue integrity, remyelination, oligodendrocytes, striatum, corpus callosum, white matter, pathogenesis, preclinical disease, iron accumulation, MRI field strength
MeSH terms: Adult, Aged, Brain, Brain Chemistry, Data Interpretation, Statistical, Female, Ferritins, Humans, Huntington Disease, Image Processing, Computer-Assisted, Iron, Magnetic Resonance Imaging, Male, Middle Aged, Myelin Sheath

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks